BB Biotech’s Halozyme HALO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | $134M | Hold |
8,322,860
| – | – | 3.37% | 12 |
|
|
2018
Q4 | $122M | Buy |
8,322,860
+75,000
| +0.9% | +$1.1M | 3.9% | 10 |
|
|
2018
Q3 | $150M | Hold |
8,247,860
| – | – | 3.97% | 10 |
|
|
2018
Q2 | $139M | Sell |
8,247,860
-272,277
| -3% | -$4.59M | 4.02% | 11 |
|
|
2018
Q1 | $167M | Hold |
8,520,137
| – | – | 4.61% | 10 |
|
|
2017
Q4 | $173M | Sell |
8,520,137
-105,914
| -1% | -$2.15M | 4.86% | 8 |
|
|
2017
Q3 | $150M | Buy |
8,626,051
+360,747
| +4% | +$6.27M | 4.15% | 10 |
|
|
2017
Q2 | $106M | Buy |
8,265,304
+515,472
| +7% | +$6.61M | 3.24% | 11 |
|
|
2017
Q1 | $100M | Buy |
7,749,832
+150,000
| +2% | +$1.94M | 3.29% | 11 |
|
|
2016
Q4 | $75.1M | Buy |
7,599,832
+220,000
| +3% | +$2.17M | 2.78% | 12 |
|
|
2016
Q3 | $89.1M | Hold |
7,379,832
| – | – | 3.13% | 12 |
|
|
2016
Q2 | $63.7M | Hold |
7,379,832
| – | – | 2.51% | 14 |
|
|
2016
Q1 | $69.9M | Buy |
7,379,832
+350,000
| +5% | +$3.31M | 2.78% | 13 |
|
|
2015
Q4 | $122M | Buy |
7,029,832
+100,000
| +1% | +$1.73M | 3.43% | 11 |
|
|
2015
Q3 | $93.1M | Buy |
6,929,832
+852,664
| +14% | +$11.5M | 2.95% | 12 |
|
|
2015
Q2 | $137M | Sell |
6,077,168
-346,202
| -5% | -$7.82M | 3.72% | 11 |
|
|
2015
Q1 | $91.7M | Sell |
6,423,370
-402,162
| -6% | -$5.74M | 2.73% | 14 |
|
|
2014
Q4 | $65.9M | Buy |
6,825,532
+395,000
| +6% | +$3.81M | 2.13% | 17 |
|
|
2014
Q3 | $58.5M | Buy |
6,430,532
+583,968
| +10% | +$5.31M | 2.38% | 14 |
|
|
2014
Q2 | $57.8M | Buy |
5,846,564
+205,000
| +4% | +$2.03M | 2.74% | 11 |
|
|
2014
Q1 | $71.7M | Buy |
5,641,564
+916,628
| +19% | +$11.6M | 3.69% | 9 |
|
|
2013
Q4 | $70.8M | Sell |
4,724,936
-791,386
| -14% | -$11.9M | 3.78% | 8 |
|
|
2013
Q3 | $60.9M | Sell |
5,516,322
-130,197
| -2% | -$1.44M | 3.31% | 9 |
|
|
2013
Q2 | $44.9M | Buy |
+5,646,519
| New | +$44.9M | 3.23% | 11 |
|